These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17319084)

  • 1. High rates of the metabolic syndrome in a First Nations Community in western Canada: prevalence and determinants in adults and children.
    Kaler SN; Ralph-Campbell K; Pohar S; King M; Laboucan CR; Toth EL
    Int J Circumpolar Health; 2006 Dec; 65(5):389-402. PubMed ID: 17319084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing rates of diabetes and cardiovascular risk in Métis Settlements in northern Alberta.
    Ralph-Campbell K; Oster RT; Connor T; Pick M; Pohar S; Thompson P; Daniels M; Deschambeau L; Werner-Leonard A; Cardinal-Lamouche S; Toth EL
    Int J Circumpolar Health; 2009 Dec; 68(5):433-42. PubMed ID: 20044962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the prevalence of diabetes risk-factors among First Nation, Métis and non-Aboriginal adults attending screening clinics in rural Alberta, Canada.
    Oster RT; Toth EL
    Rural Remote Health; 2009; 9(2):1170. PubMed ID: 19496641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada.
    Liu J; Hanley AJ; Young TK; Harris SB; Zinman B
    Int J Obes (Lond); 2006 Apr; 30(4):669-76. PubMed ID: 16302011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes care and health status of First Nations individuals with type 2 diabetes in Alberta.
    Oster RT; Virani S; Strong D; Shade S; Toth EL
    Can Fam Physician; 2009 Apr; 55(4):386-93. PubMed ID: 19366950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey.
    Ravikiran M; Bhansali A; Ravikumar P; Bhansali S; Dutta P; Thakur JS; Sachdeva N; Bhadada S; Walia R
    Diabetes Res Clin Pract; 2010 Aug; 89(2):181-8. PubMed ID: 20381187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
    Yadav D; Mahajan S; Subramanian SK; Bisen PS; Chung CH; Prasad GB
    Glob J Health Sci; 2013 Sep; 5(6):142-55. PubMed ID: 24171882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur.
    Moy FM; Bulgiba A
    BMC Public Health; 2010 Nov; 10():678. PubMed ID: 21054885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran.
    Delavari A; Forouzanfar MH; Alikhani S; Sharifian A; Kelishadi R
    Diabetes Care; 2009 Jun; 32(6):1092-7. PubMed ID: 19279302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements in indicators of diabetes-related health status among first nations individuals enrolled in a community-driven diabetes complications mobile screening program in Alberta, Canada.
    Oster RT; Shade S; Strong D; Toth EL
    Can J Public Health; 2010; 101(5):410-4. PubMed ID: 21214058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study.
    Misra R; Patel T; Kotha P; Raji A; Ganda O; Banerji M; Shah V; Vijay K; Mudaliar S; Iyer D; Balasubramanyam A
    J Diabetes Complications; 2010; 24(3):145-53. PubMed ID: 19303333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain].
    Rodríguez Bernardino A; García Polavieja P; Reviriego Fernández J; Serrano Ríos M
    Endocrinol Nutr; 2010 Feb; 57(2):60-70. PubMed ID: 20153706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations.
    Pollex RL; Hanley AJ; Zinman B; Harris SB; Khan HM; Hegele RA
    Atherosclerosis; 2006 Jan; 184(1):121-9. PubMed ID: 15869758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in Japanese-Brazilians according to specific definitions for ethnicity.
    Xavier NP; Chaim RC; Gimeno SG; Ferreira SR; Hirai AT; Padovani CR; Okoshi MP; Okoshi K
    Metab Syndr Relat Disord; 2010 Apr; 8(2):143-8. PubMed ID: 19900161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of metabolic syndrome in Asian north Indians with newly detected type 2 diabetes.
    Dhanaraj E; Bhansali A; Jaggi S; Dutta P; Jain S; Tiwari P; Ramarao P
    Indian J Med Res; 2009 May; 129(5):506-14. PubMed ID: 19675377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic syndrome in young adults type 1 diabetic patients].
    Szadkowska A; Pietrzak I; Bodalska-Lipińska J; Czerniawska E; Wlodarczyk M; Swatko-Mikolajczyk A; Bodalski J
    Przegl Lek; 2008; 65(3):126-30. PubMed ID: 18624120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and determinants of metabolic syndrome according to three definitions in middle-aged Chinese men.
    Villegas R; Xiang YB; Yang G; Cai Q; Fazio S; Linton MF; Elasy T; Xu WH; Li H; Cai H; Gao YT; Zheng W; Shu XO
    Metab Syndr Relat Disord; 2009 Feb; 7(1):37-45. PubMed ID: 19032041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.